Page last updated: 2024-09-03

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Angiogenesis, Pathologic

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Angiogenesis, Pathologic in 16 studies

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (6.25)18.2507
2000's5 (31.25)29.6817
2010's10 (62.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Allen, JS; Caruthers, SD; Hu, G; Lanza, GM; Schmieder, AH; Wickline, SA; Williams, TA; Winter, PM; Zhang, H1
Kiessling, F1
Brasch, RC; Chaopathomkul, B; Cyran, CC; Fu, Y; Rogut, V; Shames, DM; Wendland, MF1
Carme, S; Ceelen, W; De Naeyer, D; Debergh, I; Demetter, P; Pattyn, P; Robert, P; Smeets, P; Van Damme, N1
Berger, F; Lahrech, H; Nissou, MF; Perles-Barbacaru, AT; Sarraf, M; van der Sanden, B1
Haaga, J; Jin, E; Lu, ZR; Malamas, AS; Zhang, Q1
Jeong, EK; Kaneshiro, TL; Lu, ZR; Morrell, G; Parker, DL1
Barbier, EL; Beaumont, M; Farion, R; Lemasson, B; Rémy, C; Segebarth, C1
Bezy-Wendling, J; Kretowski, M; Mescam, M1
Barbier, EL; Bouchet, A; Coquery, N; Le Duc, G; Lemasson, B; Maisin, C; Rémy, C; Robert, P; Serduc, R; Troprès, I1
Blanckaert, P; Casneuf, V; Ceelen, WP; Delrue, LJ; Duyck, PC; Peeters, M; Van Damme, N1
Farion, R; Lahrech, H; Perles-Barbacaru, AT; van der Sanden, BP1
Allegrini, PR; Drevs, J; Esser, N; Fuxius, S; Hennig, J; Hugenschmidt, H; Konerding, MA; Marmé, D; Müller-Driver, R; Unger, C; Wittig, C; Wood, J1
Allegrini, PR; Baumann, D; Becquet, M; Brecht, K; Brueggen, J; Ferretti, S; McSheehy, PM; Rausch, M; Rudin, M; Schaeffer, F; Schnell, C; Wood, J1
Clement, O; Cuenod, CA; de Bazelaire, C; de Kerviler, E; Fournier, L; Frouin, F; Robert, P; Siauve, N1
Bléry, M; Contesso, G; Di Paola, R; Frouge, C; Guinebretière, JM1

Other Studies

16 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Angiogenesis, Pathologic

ArticleYear
Molecular MR imaging of neovascular progression in the Vx2 tumor with αvβ3-targeted paramagnetic nanoparticles.
    Radiology, 2013, Volume: 268, Issue:2

    Topics: Analysis of Variance; Animals; Cell Line, Tumor; Contrast Media; Disease Models, Animal; Disease Progression; Gadolinium DTPA; Heterocyclic Compounds; Hindlimb; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Least-Squares Analysis; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Neovascularization, Pathologic; Organometallic Compounds; Rabbits; Statistics, Nonparametric

2013
Science to practice: will contrast agents for molecular imaging of angiogenesis help overcome the limitations of functional vascular imaging?
    Radiology, 2013, Volume: 268, Issue:2

    Topics: Contrast Media; Disease Progression; Gadolinium DTPA; Heterocyclic Compounds; Humans; Image Enhancement; Integrin alphaVbeta3; Magnetic Resonance Imaging; Molecular Imaging; Nanoparticles; Neovascularization, Pathologic; Organometallic Compounds

2013
Evaluation of a novel macromolecular cascade-polymer contrast medium for dynamic contrast-enhanced MRI monitoring of antiangiogenic bevacizumab therapy in a human melanoma model.
    Academic radiology, 2013, Volume: 20, Issue:10

    Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Capsules; Cell Line, Tumor; Contrast Media; Drug Monitoring; Heterocyclic Compounds; Humans; Macromolecular Substances; Magnetic Resonance Imaging; Melanoma; Neovascularization, Pathologic; Organometallic Compounds; Polyethylene Glycols; Rats; Rats, Nude; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome

2013
Molecular imaging of tumor-associated angiogenesis using a novel magnetic resonance imaging contrast agent targeting αvβ 3 integrin.
    Annals of surgical oncology, 2014, Volume: 21, Issue:6

    Topics: Animals; Colorectal Neoplasms; Contrast Media; Coordination Complexes; Feasibility Studies; Heterocyclic Compounds; HT29 Cells; Humans; Integrin alphaVbeta3; Magnetic Resonance Imaging; Mice; Mice, Nude; Molecular Imaging; Molecular Probes; Muscle, Skeletal; Neovascularization, Pathologic; Organometallic Compounds; Peptides, Cyclic; Snake Venoms

2014
Rapid-Steady-State-T1 signal modeling during contrast agent extravasation: toward tumor blood volume quantification without requiring the arterial input function.
    Magnetic resonance in medicine, 2015, Volume: 73, Issue:3

    Topics: Animals; Blood Volume; Blood Volume Determination; Brain Neoplasms; Cell Line, Tumor; Computer Simulation; Contrast Media; Extravasation of Diagnostic and Therapeutic Materials; Heterocyclic Compounds; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Models, Biological; Neovascularization, Pathologic; Organometallic Compounds; Rats; Rats, Inbred F344

2015
Anti-angiogenic Effects of Bumetanide Revealed by DCE-MRI with a Biodegradable Macromolecular Contrast Agent in a Colon Cancer Model.
    Pharmaceutical research, 2015, Volume: 32, Issue:9

    Topics: Angiogenesis Inhibitors; Animals; Bumetanide; Capillary Permeability; Cell Line, Tumor; Colonic Neoplasms; Contrast Media; Cyclohexanes; DEET; Gadolinium DTPA; Heterocyclic Compounds; HT29 Cells; Humans; Macromolecular Substances; Magnetic Resonance Imaging; Mice; Mice, Nude; Neovascularization, Pathologic; Organometallic Compounds

2015
Synthesis and evaluation of globular Gd-DOTA-monoamide conjugates with precisely controlled nanosizes for magnetic resonance angiography.
    Biomacromolecules, 2008, Volume: 9, Issue:10

    Topics: Amides; Animals; Cell Line, Tumor; Chelating Agents; Contrast Media; Female; Gadolinium; Heterocyclic Compounds; Magnetic Resonance Angiography; Mice; Mice, Nude; Molecular Conformation; Nanoparticles; Neoplasms; Neovascularization, Pathologic; Organometallic Compounds

2008
Characterization of tumor angiogenesis in rat brain using iron-based vessel size index MRI in combination with gadolinium-based dynamic contrast-enhanced MRI.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2009, Volume: 29, Issue:10

    Topics: Animals; Brain Neoplasms; Cell Membrane Permeability; Contrast Media; Dextrans; Ferrosoferric Oxide; Gadolinium; Glioma; Heterocyclic Compounds; Iron; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Microvessels; Neovascularization, Pathologic; Organometallic Compounds; Rats; Rats, Wistar

2009
Multiscale model of liver DCE-MRI towards a better understanding of tumor complexity.
    IEEE transactions on medical imaging, 2010, Volume: 29, Issue:3

    Topics: Algorithms; Capillary Permeability; Carcinoma, Hepatocellular; Computer Simulation; Contrast Media; Hepatic Veins; Heterocyclic Compounds; Humans; Image Interpretation, Computer-Assisted; Liver Circulation; Liver Neoplasms; Magnetic Resonance Imaging; Models, Biological; Neovascularization, Pathologic; Organometallic Compounds

2010
Monitoring blood-brain barrier status in a rat model of glioma receiving therapy: dual injection of low-molecular-weight and macromolecular MR contrast media.
    Radiology, 2010, Volume: 257, Issue:2

    Topics: Analysis of Variance; Animals; Area Under Curve; Benzenesulfonates; Blood-Brain Barrier; Brain Neoplasms; Contrast Media; Disease Models, Animal; Glioma; Heterocyclic Compounds; Macromolecular Substances; Magnetic Resonance Imaging; Male; Neovascularization, Pathologic; Niacinamide; Organometallic Compounds; Phenylurea Compounds; Pyridines; Random Allocation; Rats; Sorafenib

2010
Assessment of neovascular permeability in a pancreatic tumor model using dynamic contrast-enhanced (DCE) MRI with contrast agents of different molecular weights.
    Magma (New York, N.Y.), 2011, Volume: 24, Issue:4

    Topics: Animals; Capillary Permeability; Cell Line, Tumor; Contrast Media; Heterocyclic Compounds; Image Enhancement; Magnetic Resonance Imaging; Male; Mice; Molecular Structure; Molecular Weight; Neovascularization, Pathologic; Organometallic Compounds; Pancreatic Neoplasms; Transplantation, Heterologous

2011
How stereological analysis of vascular morphology can quantify the blood volume fraction as a marker for tumor vasculature: comparison with magnetic resonance imaging.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2012, Volume: 32, Issue:3

    Topics: Animals; Blood Volume; Blood Volume Determination; Brain Mapping; Brain Neoplasms; Cell Line, Tumor; Contrast Media; Glioma; Heterocyclic Compounds; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Microscopy, Fluorescence; Microvessels; Models, Anatomic; Neoplasm Transplantation; Neovascularization, Pathologic; Organometallic Compounds; Rats; Rats, Wistar

2012
PTK787/ZK 222584, a specific vascular endothelial growth factor-receptor tyrosine kinase inhibitor, affects the anatomy of the tumor vascular bed and the functional vascular properties as detected by dynamic enhanced magnetic resonance imaging.
    Cancer research, 2002, Jul-15, Volume: 62, Issue:14

    Topics: Angiogenesis Inhibitors; Animals; Benzimidazoles; Blood Vessels; Capillary Permeability; Carcinoma, Renal Cell; Enzyme Inhibitors; Extravasation of Diagnostic and Therapeutic Materials; Female; Fluorescent Dyes; Heterocyclic Compounds; Kidney Neoplasms; Magnetic Resonance Angiography; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Organometallic Compounds; Phthalazines; Pyridines; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Vascular Endothelial Growth Factor; Regional Blood Flow

2002
PTK787/ZK222584, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor, reduces uptake of the contrast agent GdDOTA by murine orthotopic B16/BL6 melanoma tumours and inhibits their growth in vivo.
    NMR in biomedicine, 2005, Volume: 18, Issue:5

    Topics: Animals; Cell Line, Tumor; Cell Proliferation; Contrast Media; Female; Heterocyclic Compounds; Magnetic Resonance Imaging; Melanoma; Metabolic Clearance Rate; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Organometallic Compounds; Phthalazines; Protein-Tyrosine Kinases; Pyridines; Vascular Endothelial Growth Factor A

2005
Comprehensive model for simultaneous MRI determination of perfusion and permeability using a blood-pool agent in rats rhabdomyosarcoma.
    European radiology, 2005, Volume: 15, Issue:12

    Topics: Algorithms; Animals; Computer Simulation; Contrast Media; Heterocyclic Compounds; Image Enhancement; Image Interpretation, Computer-Assisted; Indicator Dilution Techniques; Magnetic Resonance Imaging; Models, Cardiovascular; Neovascularization, Pathologic; Organometallic Compounds; Permeability; Rats; Rats, Wistar; Reproducibility of Results; Rhabdomyosarcoma; Sensitivity and Specificity

2005
Correlation between contrast enhancement in dynamic magnetic resonance imaging of the breast and tumor angiogenesis.
    Investigative radiology, 1994, Volume: 29, Issue:12

    Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Contrast Media; Heterocyclic Compounds; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Middle Aged; Neovascularization, Pathologic; Organometallic Compounds; Prospective Studies

1994